ACIU
Price
$2.56
Change
+$0.11 (+4.49%)
Updated
Jun 26 closing price
Capitalization
260.54M
33 days until earnings call
Intraday BUY SELL Signals
EDIT
Price
$2.85
Change
+$0.11 (+4.01%)
Updated
Jun 26 closing price
Capitalization
438.9M
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACIU vs EDIT

ACIU vs EDIT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACIU vs. EDIT commentary
Jun 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a StrongBuy and EDIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2026
Stock price -- (ACIU: $2.56 vs. EDIT: $2.86)
Brand notoriety: ACIU and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 92% vs. EDIT: 219%
Market capitalization -- ACIU: $260.54M vs. EDIT: $438.9M
ACIU [@Biotechnology] is valued at $260.54M. EDIT’s [@Biotechnology] market capitalization is $438.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $124.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 5 TA indicator(s) are bullish while EDIT’s TA Score has 3 bullish TA indicator(s).

  • ACIU’s TA Score: 5 bullish, 4 bearish.
  • EDIT’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than EDIT.

Price Growth

ACIU (@Biotechnology) experienced а +6.67% price change this week, while EDIT (@Biotechnology) price change was +6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was +1916.03%.

Reported Earning Dates

ACIU is expected to report earnings on Jul 30, 2026.

EDIT is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDIT($439M) has a higher market cap than ACIU($261M). EDIT YTD gains are higher at: 39.512 vs. ACIU (-18.471). ACIU has higher annual earnings (EBITDA): -66.02M vs. EDIT (-100.08M). EDIT has more cash in the bank: 124M vs. ACIU (74.8M). ACIU has less debt than EDIT: ACIU (4.3M) vs EDIT (17.3M). EDIT has higher revenues than ACIU: EDIT (38.7M) vs ACIU (3.7M).
ACIUEDITACIU / EDIT
Capitalization261M439M59%
EBITDA-66.02M-100.08M66%
Gain YTD-18.47139.512-47%
P/E RatioN/AN/A-
Revenue3.7M38.7M10%
Total Cash74.8M124M60%
Total Debt4.3M17.3M25%
FUNDAMENTALS RATINGS
ACIU vs EDIT: Fundamental Ratings
ACIU
EDIT
OUTLOOK RATING
1..100
1223
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6347
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
6590

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACIU's Valuation (69) in the Pharmaceuticals Major industry is in the same range as EDIT (87) in the Biotechnology industry. This means that ACIU’s stock grew similarly to EDIT’s over the last 12 months.

ACIU's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as EDIT (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to EDIT’s over the last 12 months.

ACIU's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as EDIT (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to EDIT’s over the last 12 months.

EDIT's Price Growth Rating (47) in the Biotechnology industry is in the same range as ACIU (63) in the Pharmaceuticals Major industry. This means that EDIT’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as EDIT (100) in the Biotechnology industry. This means that ACIU’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIUEDIT
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
72%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
86%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signal:
Gain/Loss:
EDIT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ATWCX28.05N/A
N/A
AB Tax-Managed Wealth Apprec Strat C
FKASX50.57N/A
N/A
Federated Hermes Kaufmann Small Cap A
MLVPX18.10N/A
N/A
MFS Low Volatility Equity R3
HOMPX17.31N/A
N/A
HW Opportunities MP
AGVDX30.36-0.15
-0.49%
American Funds Global Insight C

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with KURA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+4.49%
KURA - ACIU
35%
Loosely correlated
+5.12%
AMLX - ACIU
33%
Loosely correlated
+2.01%
PCVX - ACIU
31%
Poorly correlated
+5.29%
EDIT - ACIU
31%
Poorly correlated
+4.38%
XNCR - ACIU
31%
Poorly correlated
+2.37%
More